Literature DB >> 1336563

Expression of Escherichia coli beta-galactosidase in Mycobacterium bovis BCG using an expression system isolated from Mycobacterium paratuberculosis which induced humoral and cellular immune responses.

A Murray1, N Winter, M Lagranderie, D F Hill, J Rauzier, J Timm, C Leclerc, K M Moriarty, M Gheorghiu, B Gicquel.   

Abstract

A promoter sequence, PAN, was isolated from Mycobacterium paratuberculosis and characterized. This promoter lies adjacent to, and outside, the 3' end of an IS900 insertion element. IS900 contains an open reading frame, ORF2, on the complementary strand which codes for the putative transposase of this insertion sequence. A DNA fragment containing PAN and part of ORF2 was fused to the lacZ gene and inserted into the replicative shuttle vector pRR3. Mycobacterium smegmatis and Mycobacterium bovis BCG (BCG) transformed with this plasmid exhibited beta-galactosidase activity. However, lacZ was only expressed in Escherichia coli under the control of PAN, when ORF2 was deleted. Immunization of mice with the recombinant M. bovis BCG expressing lacZ resulted in the induction of a high humoral and cellular response directed against beta-galactosidase. The PAN-ORF2 expression system may prove to be particularly useful for cloning and expression of heterologous genes in the BCG vaccine strain.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1336563     DOI: 10.1111/j.1365-2958.1992.tb02201.x

Source DB:  PubMed          Journal:  Mol Microbiol        ISSN: 0950-382X            Impact factor:   3.501


  19 in total

1.  Genetic analysis of the Mycobacterium smegmatis rpsL promoter.

Authors:  T J Kenney; G Churchward
Journal:  J Bacteriol       Date:  1996-06       Impact factor: 3.490

Review 2.  Mycobacterium avium subsp. paratuberculosis in Veterinary Medicine.

Authors:  N B Harris; R G Barletta
Journal:  Clin Microbiol Rev       Date:  2001-07       Impact factor: 26.132

Review 3.  Recombinant Mycobacterium bovis BCG as an HIV vaccine vector.

Authors:  Rosamund Chapman; Gerald Chege; Enid Shephard; Helen Stutz; Anna-Lise Williamson
Journal:  Curr HIV Res       Date:  2010-06       Impact factor: 1.581

4.  Effect of growth phase and acid shock on Helicobacter pylori cagA expression.

Authors:  M Karita; M K Tummuru; H P Wirth; M J Blaser
Journal:  Infect Immun       Date:  1996-11       Impact factor: 3.441

5.  Comparison of immune responses of mice immunized with five different Mycobacterium bovis BCG vaccine strains.

Authors:  M R Lagranderie; A M Balazuc; E Deriaud; C D Leclerc; M Gheorghiu
Journal:  Infect Immun       Date:  1996-01       Impact factor: 3.441

Review 6.  Paratuberculosis.

Authors:  C Cocito; P Gilot; M Coene; M de Kesel; P Poupart; P Vannuffel
Journal:  Clin Microbiol Rev       Date:  1994-07       Impact factor: 26.132

7.  Humoral and cellular immune responses in mice immunized with recombinant Mycobacterium bovis Bacillus Calmette-Guérin producing a pertussis toxin-tetanus toxin hybrid protein.

Authors:  B Abomoelak; K Huygen; L Kremer; M Turneer; C Locht
Journal:  Infect Immun       Date:  1999-10       Impact factor: 3.441

8.  Protection of sheep against caseous lymphadenitis by use of a single oral dose of live recombinant Corynebacterium pseudotuberculosis.

Authors:  A L Hodgson; M Tachedjian; L A Corner; A J Radford
Journal:  Infect Immun       Date:  1994-12       Impact factor: 3.441

9.  Escherichia coli-mycobacteria shuttle vectors for operon and gene fusions to lacZ: the pJEM series.

Authors:  J Timm; E M Lim; B Gicquel
Journal:  J Bacteriol       Date:  1994-11       Impact factor: 3.490

10.  Regulation of expression of mas and fadD28, two genes involved in production of dimycocerosyl phthiocerol, a virulence factor of Mycobacterium tuberculosis.

Authors:  Tatiana D Sirakova; Ann Marie Fitzmaurice; Pappachan Kolattukudy
Journal:  J Bacteriol       Date:  2002-12       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.